Evidence map›Paper›PMID 29198213›Full record

ArticleInternational psychogeriatrics2018

Presence of neuroticism and antidepressant remission rates in late-life depression: results from the Neurobiology of Late-Life Depression (NBOLD) study.

David C Steffens, Rong Wu, James J Grady, Kevin J Manning

Open access · diamondAbstract read
In one paragraph

Article in International psychogeriatrics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Moderators of treatment response in late-life depression.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Review
  5. Article
  6. Effects of Longitudinal Changes in Neuroticism and Stress on Cognitive Decline.The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2023
    Observational
  7. Article
  8. Article
  9. Article
  10. Prevalence of affective disorders and dementia in inflammatory polyarthropathies.European archives of psychiatry and clinical neuroscience · 2020
    Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

David C SteffensDepartments of Psychiatry,University of Connecticut School of Medicine,Farmington,Connecticut,USA.
Rong WuBiostatistics Center,Connecticut Institute for Clinical and Translational Science,University of Connecticut School of Medicine,Farmington,Connecticut,USA.
James J GradyBiostatistics Center,Connecticut Institute for Clinical and Translational Science,University of Connecticut School of Medicine,Farmington,Connecticut,USA.
Kevin J ManningDepartments of Psychiatry,University of Connecticut School of Medicine,Farmington,Connecticut,USA.
University of Connecticut · US

Funding

Phenotype Predictors of Cognitive Outcomes in Geriatric DepressionR01MH108578 · NIMH · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI STEFFENS, DAVID C. · 2016 to 2025
$5.5M
Neurobiology and Adverse Outcomes of Neuroticism in Late-life DepressionR01MH096725 · NIMH · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI STEFFENS, DAVID C. · 2012 to 2016
$3.4M
NIMH NIH HHS R01 MH096725NIMH NIH HHS R01 MH108578
6 · The paper itself

Abstract

ABSTRACTNeuroticism in older adults is common yet understudied, particularly its effects on depression treatment outcomes. We hypothesized that presence of high neuroticism would be associated with lower 12-week remission rates in older depressed sertraline-treated patients. In this longitudinal cohort study, 43 depressed older adults completed the Revised NEO Personality Inventory (NEO PI-R). A study psychiatrist administered the Montgomery Ǻsberg Depression Rating Scale (MADRS), and the Cumulative Illness Rating Scale (CIRS, a measure of medical burden) at baseline, and the MADRS at each clinical visit. All subjects began open-label sertraline treatment and were followed over 12 weeks with clinically indicated flexible dosing and an option to switch antidepressants. We used regression analyses to examine factors related to 12-week remission of depression (MADRS score < 8) and final MADRS score. We found that higher total neuroticism (odds ratio (OR) = 0.963, 95% confidence interval (CI) = 0.928-1.000) and a neuroticism subscale, stress vulnerability (OR = 0.846, 95% CI = 0.728-0.983), were associated with lower likelihood of remission among both the intention-to-treat group and sertraline completers. Findings remained significant after controlling for baseline MADRS and CIRS score. In conclusion, assessment of personality, particularly features of neuroticism, may be important in management of late-life depression. Future studies should determine if depressed patients high in neuroticism may benefit from psychotherapy focusing on emotional regulation and stress management.

Indexed as

DepressionNeuroticismSertralineAgedAntidepressive AgentsDose-Response Relationship, DrugDrug MonitoringDrug ResistanceFemaleHumansLate Onset DisordersMaleMiddle AgedPersonality InventoryPsychiatric Status Rating ScalesRemission InductionAntidepressive AgentsSertralinedepressionelderlyneuroticismtreatment

Identifiers

PMID29198213
PMCPMC5986581
OpenAlexW2774435404

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.